Research On Global Markets has announced the addition of a market research report titled "Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024)" to their offering. According to the report, the Asia-Pacific self-monitoring blood glucose devices market is expected to expand at a CAGR of 6.34% during the 2019-2024 period, owing to technological breakthroughs, rising obesity, and the increasing prevalence of diabetes.

The research report published by Research On Global Markets features a comprehensive analysis of the self-monitoring blood glucose devices market in the Asia-Pacific based on product and end user. Based on products, the testing strips segment is expected to hold the highest market share (81.64%) in 2019. Analysts predict that thanks to the development of innovative testing strips, and a massive increase in the incidence of diabetes, the segment will see a high CAGR of 6.94% during the forecasted period. The glucometers segment, on the other hand, is expected to remain steady during the forecasted period. However, variations in results due to external and physiological factors will lead to a comparatively low CAGR (4.95%) for the segment during the 2019-2024 period.

In terms of end users, the shift of medical services to decentralized surroundings like patients’ homes and the development of portable and user-friendly blood glucose monitoring devices will enable the home settings segment to expand at a CAGR of 6.82% during the 2019-2024 period. The hospitals sector will generate almost 7% of the total market revenue by 2019, and is anticipated to expand at a CAGR of 4.78% during the forecast period.

Research On Global Markets tracks the performance of the self-monitoring blood glucose devices market across the key geographies of the Asia-Pacific region. Among the prominent countries in the Asia-Pacific, China is expected to expand at a CAGR of 6.62% during the forecast period, while healthcare initiatives and government programs in India will enable the market in the country to expand at a CAGR of 6.46%.

Research On Global Markets tracks the performance of the major players operating in the Asia-Pacific self-monitoring blood glucose devices market including Wockhardt, Roche Holdings, Abbott Laboratories, i-Sens, and Terumo Medical, among others.

Key highlights of this report:

- Asia-Pacific self-monitoring blood glucose devices market – overview
- Historical market revenue (USD Bn)
- Forecasted market revenue (USD Bn)
- Country-wise market revenue (USD Bn)
- Asia-Pacific self-monitoring blood glucose devices market – based on products
- Asia-Pacific self-monitoring blood glucose devices market – based on end users
- Market trends
- Market drivers
- Market challenges
- Analysis of the competitive landscape

This report has been formulated and designed with the purpose of giving businesses a concise understanding of the demand for self-monitoring blood glucose devices across the key geographies of the Asia-Pacific region to determine the viability of the market, develop strategies based on the drivers, and to help brands identify competition and respond accordingly.

Check out the Research on Global Markets report featured in this article:

Asia-Pacific Self-monitoring Blood Glucose Devices Market (2019-2024)
September 2019 | 70 Pages | SKU: 2018238

NameAnkita Basu
Emailankita.basu@netscribes.com
US Toll-Free: 18888313350
M: +91 9903154956